Acadia Pharma (ACAD) Tops Q4 EPS by 3c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $28.38 -3.63%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q4 EPS of ($0.55), $0.03 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $44.32 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
